The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 10 , ISSUE 2 ( March, 2009 ) > List of Articles

RESEARCH ARTICLE

A Randomized Clinical Trial to Compare Plaque Inhibition of a Sodium Fluoride/Potassium Nitrate Dentifrice versus a Stabilized Stannous Fluoride/ Sodium Hexametaphosphate Dentifrice

Matthew L. Barker, Philip G. Bellamy, Nichelle Khera, Trevor N. Day, Andrew J. Mussett

Citation Information : Barker ML, Bellamy PG, Khera N, Day TN, Mussett AJ. A Randomized Clinical Trial to Compare Plaque Inhibition of a Sodium Fluoride/Potassium Nitrate Dentifrice versus a Stabilized Stannous Fluoride/ Sodium Hexametaphosphate Dentifrice. J Contemp Dent Pract 2009; 10 (2):1-9.

DOI: 10.5005/jcdp-10-2-1

License: CC BY-NC 3.0

Published Online: 01-03-2009

Copyright Statement:  Copyright © 2009; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim

To compare the plaque inhibition efficacy of a sodium fluoride/potassium nitrate (NaF/KNO3 with 1450 ppm F) test dentifrice to a 0.454% stannous fluoride/sodium hexametaphosphate/sodium fluoride positive control dentifrice (SnF2/SHMP with 1450 ppm F).

Methods and Materials

Twenty-five subjects were randomized to a two-period, two-treatment, double blind crossover sequence using NaF/KNO3 (Sensodyne® ProNamel™ dentifrice) and SnF2/SHMP (blend-a-med®* EXPERT GUMS PROTECTION dentifrice). Each treatment was conducted with a standard manual toothbrush (Oral-B® P35 Indicator). Digital plaque image analysis (DPIA) was used on three consecutive days to evaluate: (a) overnight plaque formation (A.M. pre-brushing); (b) following 40 seconds of brushing with the test product (A.M. post-brushing); and (c) mid-afternoon (P.M.). Images were analysed using an objective computer algorithm to calculate the total area of visible plaque. A four-day washout period was instituted for the crossover phase.

Results

All 25 subjects completed the study. The SnF2/SHMP positive control dentifrice provided statistically significantly lower levels of plaque area coverage versus the NaF/KNO3 test dentifrice at each timepoint. For the SnF2/SHMP dentifrice, plaque coverage was 23.0% lower (p<0.0001) at A.M. pre-brushing, 17.3% (p=0.0163) lower at A.M. post-brushing, and 22.6% (p= 0.0004) lower at the P.M. measure relative to the NaF/KNO3 dentifrice.

Conclusion

The SnF2/SHMP dentifrice (blend-a-med® EXPERT GUMS PROTECTION) inhibits plaque regrowth both overnight and during the day to a significantly greater degree than the NaF/KNO3 dentifrice (Sensodyne® ProNamel™).

Clinical Significance

Dentists recommending an effective home use dentifrice for patients experiencing dentinal hypersensitivity and/or dental erosion may previously have needed to compromise on other key benefits, such as plaque control. blend-a-med® EXPERT GUMS PROTECTION is a dentifrice when integrated into an oral hygiene routine can provide a proven treatment for hypersensitivity, dental erosion, and a reduction in the regrowth of plaque.

Citation

Bellamy PG, Khera N, Day TN, Barker ML, Mussett AJ. A Randomized Clinical Trial to Compare Plaque Inhibition of a Sodium Fluoride/Potassium Nitrate Dentifrice versus a Stabilized Stannous Fluoride/ Sodium Hexametaphosphate Dentifrice. J Contemp Dent Pract 2009 March; (10)2:001-009.

* Also branded Crest® and Ipana, depending on the country.


PDF Share
  1. Periodontal diseases in Europe Periodontol 2000 2002; 29(1):104-121.
  2. Dental bacterial plaques. Nature and role in periodontal disease. J Clin Periodontol 1991; 18(6):441-446.
  3. Principles of aetiology and pathogenesis governing the treatment of periodontal disease. Int Dent J 1983; 33(2):119-126.
  4. A systematic review of powered vs. manual toothbrushes in periodontal cause-related therapy. J Clin Periodontol 2002; 29(Suppl. 3):39-54.
  5. Clinical evaluations of plaque removal efficacy: An advanced rotating-oscillating power toothbrush versus a sonic toothbrush. J Clin Dent 2007; 18(4):106-111.
  6. The Oral-B CrossAction manual toothbrush: A 5-year literature review. J Can Dent Assoc 2006; 72(4):323-323k.
  7. The formation and control of dental plaque – An overview. J Appl Bacteriol 1992; 73(4):269-278.
  8. Agents for management of plaque and gingivitis. J Dent Res 1992; 71(7):1450-1454.
  9. Modes of action of currently known chemical anti-plaque agents other than chlorhexidine. J Dent Res 1989; 68(Spec Iss Nov.):1609-1616.
  10. The efficacy of potassium salts as agents for treating dentin hypersensitivity. J Orofac Pain 2000; 14(1):9-19.
  11. Erosion - Diagnosis and Risk Factors. Clin Oral Investig 2008; 12(Suppl. 1):5-13.
  12. The World Oral Health Report 2003:Continuous improvement of oral health in the 21st century - The approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol 2003; 31(Suppl. 1):3-24.
  13. Dentine hypersensitivity - An enigma? A review of terminology, epidemiology, mechanisms, aetiology and management. Br Dent J 1999; 187(11):606-611.
  14. Periodontal conditions in Europe. J Clin Periodontol 1991; 18(6):353-357.
  15. Chemical inhibition of plaque. J Clin Periodontol 1980; 7(6):431-442.
  16. Human clinical studies of antiplaque and antigingivitis agents dosed from a dentifrice. In: Rolla G, Embery G. Clinical and Biological Aspects of Dentifrices. Oxford. Oxford University Press 1992:181-204.
  17. The effect of a new toothpaste containing potassium nitrate and triclosan on gingival health, plaque formation and dentine hypersensitivity. J Clin Periodontol 2005; 32(1):53-58.
  18. A ‘return’ to stannous fluoride dentifrices. J Clin Dent 1995; 6(Spec Iss II):29-36.
  19. Efficacy and safety of a novel stabilized stannous fluoride and sodium hexametaphosphate dentifrice for dental hypersensitivity. J Contemp Dent Pract 2006; 7(2):1-10.
  20. Progress regarding the use of stannous fluoride in clinical dentistry. J Clin Dent 1995; 6(Spec Iss II):37-40.
  21. Anti-gingivitis efficacy of a stabilized 0.454% Stannous Fluoride/Sodium Hexametaphosphate dentifrice: a controlled 6-month clinical trial. J Clin Periodontol 2005; 32:75-80.
  22. Overnight malodour effect with a 0.454% stabilized stannous fluoride sodium hexametaphosphate dentifrice. Compend Contin Educ Dent 1995; 28(12):658-661.
  23. Effect of stannous fluoride toothpaste on erosion-like lesions: An in vivo study. Eur J Oral Sci 2006; 114(3):180-183.
  24. The protective effects of toothpaste against erosion by orange juice: Studies in situ and in vitro. J Dent 2007; 35(6):476-481.
  25. Comparison of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice and a zinc citrate dentifrice on plaque formation measured by digital plaque imaging (DPIA) with white light illumination. J Clin Dent 2008; 19(2):48-54.
  26. Application of digital imaging in tooth whitening randomized controlled trials. Am J Dent 2007;20(Spec Iss):7A-14A.
  27. A 24-hour dental plaque prevention study with a stannous fluoride dentifrice containing hexametaphosphate. J Contemp Dent Pract 2006; 7(3):001-011.
  28. Effect of a stannous fluoride dentifrice on plaque formation and removal: a digital plaque imaging study. J Clin Dent 2007; 18(1):21-24.
  29. J Dent Res 2007;86(Spec Iss):Abstract 1134.
  30. Effects of nine weeks’ use of a new stabilized stannous fluoride dentifrice on intrinsic plaque virulence expressed as acidogenicity and regrowth: A modified PGRM study. J Clin Dent 1995; 6:71-79.
  31. Comparative clinical effectiveness of stannous fluoride dentifrice in treating gingivitis. J Dent Res 2007;86(Spec Iss):Abstract 1191.
  32. The comparative efficacy of stabilized stannous fluoride/sodium hexametaphosphate dentifrice and sodium fluoride/triclosan/ copolymer dentifrice for the control of gingivitis: A 6-month randomized clinical study. J Periodontol 2004; 75:1592-1599.
  33. Antigingivitis efficacy of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice in subjects previously nonresponsive to a triclosan/copolymer dentifrice. Compend Contin Educ Dent 2005; 26(Suppl 1): 12-18.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.